FIELD: biotechnology.
SUBSTANCE: disclosed is use of keratin with an amino acid sequence presented in SEQ ID NO: 1, for preparing a drug having antipyretic, analgesic, antitussive, expectorant, anticonvulsant and antiepileptic action. Also disclosed is the use of a nucleic acid molecule coding said keratin for producing said drug, using an expression vector and a host cell for expressing said keratin. Also disclosed is a pharmaceutical composition containing said keratin.
EFFECT: invention can be effectively used to produce a drug having antipyretic, analgesic, antitussive, expectorant, anticonvulsant and antiepileptic action.
10 cl, 3 dwg, 9 tbl, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| KERATIN BD-1, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2020 |
|
RU2825994C1 |
| KERATIN BD-6, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2020 |
|
RU2825993C1 |
| KERATIN BD-11, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2020 |
|
RU2825992C1 |
| KERATIN BD-10, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2020 |
|
RU2823655C1 |
| KERATIN BD-13, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2020 |
|
RU2825991C1 |
| KERATIN BD-4, PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS, AND USE THEREOF | 2020 |
|
RU2824893C1 |
| THERAPEUTIC BIOPREPARATION FOR TREATING HEPATOCELLULAR CARCINOMA | 2014 |
|
RU2739218C2 |
| GENE THERAPY FOR THE TREATMENT OF HEMOPHILIA A | 2017 |
|
RU2762257C2 |
| DELIVERY, CONSTRUCTION AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION AND USE IN THERAPY | 2013 |
|
RU2721275C2 |
| PROTEIN AND VACCINE AGAINST SARS-CoV-2 INFECTION | 2020 |
|
RU2815060C1 |
